Systematic Screening of Tryptophan Metabolism Identifies Site- and Microbiota-Dependent Signatures of Tryptophan Utilization in Experimental Colitis
International Journal of Tryptophan Research · 2026-08 · 19
DOI: 10.1177/11786469261472316 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Tryptophan Research, online erschienen am 11.08.2026. Verfasst von Lina Wehkamp und 17 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Joachim Herz Stiftung, BMBF.
Abstract (Originalsprache)
Background
Altered tryptophan (Trp) metabolism and disrupted nicotinamide adenine dinucleotide (NAD + ) synthesis are hallmarks of IBD, yet how intestinal microbiota contribute to these metabolic shifts during intestinal inflammation remains poorly understood.
Methods
We used targeted metabolomics to systematically profile Trp- and NAD + -related metabolites across multiple biological compartments – including tissues, luminal contents, stool and serum – in mice treated with dextran sulfate sodium (DSS) alone or in combination with a broad-spectrum antibiotic (ABX) cocktail.
Results
Microbial depletion significantly attenuated colitis and increased host Trp bioavailability, implicating the gut microbiota as a competitive Trp consumer. In DSS colitis, Trp degradation along the kynurenine pathway (KP) was exaggerated but blocked at the key KP enzyme quinolinate phosphoribosyltransferase (QPRT), resulting in mucosal NAD(H) depletion. ABX co-treatment normalized metabolite conversion along the KP and restored mucosal NAD(H) levels, revealing a dual role of the gut microbiota during colitis: while they compete with the host for Trp utilization, they simultaneously shape host KP regulation and NAD + de novo synthesis, supporting host energy homeostasis.
Conclusion
Our findings demonstrate that mucosal NAD + de novo synthesis is a microbially regulated metabolic process that alleviates intestinal inflammation and may represent a novel therapeutic target in IBD through modulation of the gut microbiota or their metabolites.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
- Department of Internal Medicine I, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
- Department of Biochemistry and Molecular Biology, The Huck Institute of the Life Sciences, Pennsylvania State University, University Park, PA, USA.
- Nova Scotia Government, Department of Health and Wellness, Halifax, NS, Canada.
- Institute for Human Nutrition and Food Science, Nutriinformatics, Kiel University, Germany.
ORCID-Profile: Lina Wehkamp, Konrad Aden
Förderung
- NIGMS NIH HHS
- Joachim Herz Stiftung
- BMBF
- howard hughes medical institute
- burroughs wellcome fund
- DFG
- national institutes of health
- else krönerfreseniusstiftung
Zitieren
APA
Wehkamp, L., Alsaadi, A. I., Harris, D. M. M., Yu, M., Mekdoud, T., Bornhäuser, J., Springer, E., Gilloteau, C., Pothakamury, A. A., Smith, J. D., Jenkins, B. C., Guggeis, M., Sommer, F., Waschina, S., Rosenstiel, P., Schreiber, S., McReynolds, M. R., & Aden, K. (2026). Systematic Screening of Tryptophan Metabolism Identifies Site- and Microbiota-Dependent Signatures of Tryptophan Utilization in Experimental Colitis. International Journal of Tryptophan Research, 19. https://doi.org/10.1177/11786469261472316
Vancouver
Wehkamp L, Alsaadi AI, Harris DMM, Yu M, Mekdoud T, Bornhäuser J, et al. Systematic Screening of Tryptophan Metabolism Identifies Site- and Microbiota-Dependent Signatures of Tryptophan Utilization in Experimental Colitis. International Journal of Tryptophan Research. 2026;19. doi:10.1177/11786469261472316
BibTeX
@article{Wehkamp2026,
author = {Wehkamp, Lina and Alsaadi, Abrar I and Harris, Danielle M M and Yu, Meiping and Mekdoud, Taous and Bornhäuser, Johanna and Springer, Eva and Gilloteau, Clara and Pothakamury, Anant A and Smith, Jaclyn D and Jenkins, Brenita C and Guggeis, Martina and Sommer, Felix and Waschina, Silvio and Rosenstiel, Philip and Schreiber, Stefan and McReynolds, Melanie R and Aden, Konrad},
title = {Systematic Screening of Tryptophan Metabolism Identifies Site- and Microbiota-Dependent Signatures of Tryptophan Utilization in Experimental Colitis},
journal = {International Journal of Tryptophan Research},
year = {2026},
volume = {19},
doi = {10.1177/11786469261472316}
}
EUVIMED